Reflex Molecular Testing May Enhance Targeted Therapy Benefit in Early-Stage Lung Cancer
Jobelle Baldonado, MD, highlights the emergence of targeted therapies and the need for reflex-ordered molecular testing in early-stage lung cancer.
Source: onclive.com